Key Highlights

● Third-quarter Revenue was $823 million, up 5.1%, with organic growth of 7.0%.

● Adjusted EBITDA Margin widened 90 basis points to 28.6%.

● The Industrial segment margin reached a record 36.1%.

● The software segment recorded a $3 million operating loss.

UL Solutions Inc. (NYSE:ULS) has spent much of the past month in the spotlight for its largest-ever Acquisition and a firmer organic growth outlook. Less attention has gone to the one segment that moved in the opposite direction. In the third quarter, the safety science company's Risk & Compliance Software Business swung to a small operating loss while its testing-heavy Industrial and Consumer segments posted record margins. That divergence may matter for how investors assess the durability of the company's margin gains as it absorbs a large new testing business.

Latest Company Context

UL Solutions reported third-quarter revenue of $823 million on Nov. 3, up 5.1%, with organic growth of 7.0%, according to the Earnings release filed with the SEC. Net Income rose 10.4% to $117 million, adjusted EBITDA rose 8.3% to $235 million and the adjusted EBITDA margin widened 90 basis points to 28.6%. Organic growth was 8.4% in Industrial, 5.9% in Consumer and 4.7% in Risk & Compliance Software. The Industrial segment margin reached a record 36.1% and Consumer a record 21.4%, while the software segment recorded a $3 million operating loss and its adjusted EBITDA margin fell to 18.9% from 29.7% a year earlier, a result management called disappointing. The company raised its 2026 organic growth outlook to about 6.5% and kept its adjusted EBITDA margin outlook at about 27.0%.

Key Business and index Drivers

The software segment is small relative to testing and certification, but it has historically offered Recurring Revenue and higher margins, so a sustained slump could dilute the company-wide mix. The April sale of the Employee Health and Safety software business for $201 million also changed the segment's composition, which may complicate year-over-year comparisons. On the other side of the ledger, Industrial Demand appears robust. Management cited energy-transition and materials orders growing faster than revenue, persistent Data Center tailwinds and three new AI data center certification programs. The Eurofins Electrical and Electronics acquisition, closed Oct. 1 for about $686 million, adds further weight to testing. Regulation is another factor: the FCC voted to bar Chinese labs from testing electronics for U.S. market authorization, and while China represented about 25% of 2025 revenue, management said it expects no material impact.

What Investors Should Watch

UL Solutions has not announced a date for its fourth-quarter report; based on its reporting pattern, results could arrive in early 2027. Investors may watch whether management outlines a recovery path for software margins or signals further portfolio pruning in that segment. The full-year adjusted EBITDA margin target of about 27.0% includes roughly 90 basis points of incremental transaction costs, and the company now expects 2026 transaction and integration costs of $37 million to $40 million, so the fourth quarter could show how those charges evolve once E&E is consolidated. Debt fell from $766 million at quarter end to $689 million by Oct. 30 after the DQS stake sale, and further deleveraging may also be watched. Any initial 2027 outlook, including expectations for the software business and E&E integration, could be a key data point.

Record Testing Margins, a Softer Software Arm

UL Solutions' third quarter showed a company whose testing franchises are running at record profitability while its software arm is under pressure. With the E&E deal tilting the portfolio further toward testing, the software segment's weight is shrinking, yet its margin trajectory may still influence how investors view overall earnings quality. The coming quarters could clarify whether the software weakness is a temporary reset or a more lasting drag on the mix.